Tranexamic acid in cardiac surgery: Are low doses enough?

[1]  P. Karanicolas,et al.  Current Evidence and Future Directions of Tranexamic Acid Use, Efficacy, and Dosing for Major Surgical Procedures. , 2020, Journal of cardiothoracic and vascular anesthesia.

[2]  Raja R. Palvadi,et al.  Society of Cardiovascular Anesthesiologists Clinical Practice Improvement Advisory for Management of Perioperative Bleeding and Hemostasis in Cardiac Surgery Patients. , 2019, Journal of cardiothoracic and vascular anesthesia.

[3]  Hansong Sun,et al.  Outcome impact of different tranexamic acid regimens in cardiac surgery with cardiopulmonary bypass (OPTIMAL): Rationale, design, and study protocol of a multicenter randomized controlled trial. , 2019, American heart journal.

[4]  E. Hessel.  What's New in Cardiopulmonary Bypass. , 2019, Journal of cardiothoracic and vascular anesthesia.

[5]  H. Ji,et al.  Different dose regimes and administration methods of tranexamic acid in cardiac surgery: a meta-analysis of randomized trials , 2019, BMC Anesthesiology.

[6]  P. Myles,et al.  Tranexamic acid modulates the immune response and reduces postsurgical infection rates. , 2019, Blood advances.

[7]  M. Maegele,et al.  The role of evidence-based algorithms for rotational thromboelastometry-guided bleeding management , 2019, Korean journal of anesthesiology.

[8]  I. Roberts,et al.  What concentration of tranexamic acid is needed to inhibit fibrinolysis? A systematic review of pharmacodynamics studies , 2019, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[9]  Qiongyao Mou,et al.  Blood clot parameters: Prejudgment of fibrinolysis in thromboelastography. , 2018, Clinica chimica acta; international journal of clinical chemistry.

[10]  C. Longstaff.  Measuring fibrinolysis: from research to routine diagnostic assays , 2018, Journal of thrombosis and haemostasis : JTH.

[11]  A. Koster,et al.  Antifibrinolytic Therapy and Perioperative Considerations. , 2017, Anesthesiology.

[12]  H. Iso,et al.  Evaluating the Effect on Mortality of a No-Tranexamic acid (TXA) Policy for Cardiovascular Surgery. , 2017, Journal of cardiothoracic and vascular anesthesia.

[13]  A. Koster,et al.  2017 EACTS/EACTA Guidelines on patient blood management for adult cardiac surgery. , 2018, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[14]  A. Zaky.  Thromboelastometry Versus Rotational Thromboelastography in Cardiac Surgery , 2017, Seminars in cardiothoracic and vascular anesthesia.

[15]  Neal S. Gerstein,et al.  Antifibrinolytic Agents in Cardiac and Noncardiac Surgery: A Comprehensive Overview and Update. , 2017, Journal of cardiothoracic and vascular anesthesia.

[16]  P. Myles,et al.  Tranexamic Acid in Patients Undergoing Coronary‐Artery Surgery , 2017, The New England journal of medicine.

[17]  Kenichi A. Tanaka,et al.  Practical Use of Thromboelastometry in the Management of Perioperative Coagulopathy and Bleeding. , 2017, Transfusion medicine reviews.

[18]  B. Orser,et al.  Tranexamic acid–associated seizures: Causes and treatment , 2015, Annals of neurology.

[19]  A. Jerath,et al.  Tranexamic acid: a clinical review. , 2015, Anaesthesiology intensive therapy.

[20]  A. Koster,et al.  Antifibrinolytic Therapy for Cardiac Surgery: An Update. , 2015, Anesthesiology.

[21]  D. Faraoni,et al.  Experimental model of hyperfibrinolysis designed for rotational thromboelastometry in children with congenital heart disease , 2015, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[22]  M. Ranucci.  Hemostatic and Thrombotic Issues in Cardiac Surgery , 2015, Seminars in Thrombosis & Hemostasis.

[23]  A. Klein,et al.  Haemostatic management of cardiac surgical haemorrhage , 2015, Anaesthesia.

[24]  D. Faraoni,et al.  Effect of two doses of tranexamic acid on fibrinolysis evaluated by thromboelastography during cardiac surgery: A randomised, controlled study , 2014, European journal of anaesthesiology.

[25]  F. Sellke,et al.  Universal definition of perioperative bleeding in adult cardiac surgery. , 2014, The Journal of thoracic and cardiovascular surgery.

[26]  Kenichi A. Tanaka,et al.  Lessons from the aprotinin saga: current perspective on antifibrinolytic therapy in cardiac surgery , 2010, Journal of Anesthesia.

[27]  S. Brister,et al.  Coagulation disorders of cardiopulmonary bypass: a review , 2004, Intensive Care Medicine.

[28]  J. Butterworth,et al.  Pharmacokinetics of Tranexamic Acid during Cardiopulmonary Bypass , 2002, Anesthesiology.

[29]  Lance J. Oyen,et al.  Plasma Tranexamic Acid Concentrations During Cardiopulmonary Bypass , 2001, Anesthesia and analgesia.

[30]  J. Horrow,et al.  The Dose-Response Relationship of Tranexamic Acid , 1995 .